Clinical Trials Browser

Phase 1 × Interventional × Certolizumab Pegol × Clear all

NCT02120807 2023-01-26

Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas

Phase 1 Completed

Adenocarcinoma of Lung